HN

Hitesh Natvarlal Mevada

Active Director Managing Director DIN 01820149
DIN 01820149 First appointment Oct 2008 Primary industry Machinery and Equipment
Unlock full profile Investments · shareholding · contact details
Current companies 5 active board seats
Past companies 1 historical roles
Total affiliations 6 Since Oct 2008
Shareholding value •••• Premium profile

About Hitesh Natvarlal Mevada

Data last updated:

Hitesh Natvarlal Mevada is a Managing Director at N.K.P. Pharma Private Limited (since 2008), Designated Partner at Sterileair Solution Technologies Llp (since 2017) and Director at Aseptic Technocraft Private Limited (since 2017), and holds 2 more current directorships. The companies operate in Machinery and Equipment, Pharma and Information Technology. The 3 current companies with reported revenue have a combined latest revenue of ₹112 Cr; the largest is N.K.P. Pharma Private Limited at ₹103 Cr (FY 2025). Earlier, Hitesh Natvarlal Mevada was a Designated Partner at Strillen Air Solution Technologies Llp (from 2017).

DIN 01820149
Primary Designation Managing Director
Industry Machinery and Equipment
First Appointment 08 Oct 2008
Oldest Company Age 18 yrs
Largest company N.K.P. Pharma Private Limited · ₹103 Cr (FY 2025)
Combined revenue ₹112 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
N.K.P. Pharma Private Limited U01403GJ2008PTC055212
Managing Director08 Oct 20082008₹103 Cr (FY 2025)Active
Designated Partner01 Jun 20172017₹8.77 Cr (FY 2023)Active
Aseptic Technocraft Private Limited U24100GJ2017PTC098746
Director18 Aug 20172017₹7 Lakh (FY 2025)Active
Designated Partner23 Nov 20202020Active
Designated Partner21 Oct 20202020Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner23 May 20172017Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Url Aseptic Automation Llp
Aseptic Automation Llp
N.K.P. Pharma Private Limited
Aseptic Technocraft Private Limited
Premium access

Shareholding and investment profile for Hitesh Natvarlal Mevada

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Hitesh Natvarlal Mevada

Hitesh Natvarlal Mevada currently holds 5 directorships: N.K.P. Pharma Private Limited (Managing Director, since 08 Oct 2008, revenue ₹103 Cr (FY 2025)); Sterileair Solution Technologies Llp (Designated Partner, since 01 Jun 2017, revenue ₹8.77 Cr (FY 2023)); Aseptic Technocraft Private Limited (Director, since 18 Aug 2017, revenue ₹7 Lakh (FY 2025)); Url Aseptic Automation Llp (Designated Partner, since 23 Nov 2020); Aseptic Automation Llp (Designated Partner, since 21 Oct 2020).

Hitesh Natvarlal Mevada was first appointed on 08 Oct 2008 as Managing Director at N.K.P. Pharma Private Limited. The most recent appointment on record is 23 Nov 2020 at Url Aseptic Automation Llp.

The 3 current companies of Hitesh Natvarlal Mevada that report revenue have a combined latest revenue of ₹112 Cr: N.K.P. Pharma Private Limited ₹103 Cr (FY 2025); Sterileair Solution Technologies Llp ₹8.77 Cr (FY 2023); Aseptic Technocraft Private Limited ₹7 Lakh (FY 2025).

Hitesh Natvarlal Mevada held 1 earlier board appointment: Strillen Air Solution Technologies Llp (Designated Partner, from 23 May 2017).

The current boards of Hitesh Natvarlal Mevada's companies include Darshan Natvarlal Mevada (N.K.P. Pharma Private Limited), Mann Hitesh Mevada (N.K.P. Pharma Private Limited), Prem Darshan Mevada (N.K.P. Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available